Cytotoxic Effects Of Selective Inhibitor ‘Aurora Kinase B’ On Viability And Metabolic Features Of Human Promyelocytic Leukemia Cell Line
Background and Aim: A goal of modern cancer research is to reach targeted therapies with drugs having fewer side effects. AZD1152 is a highly specific inhibitor of Aurora Kinase B, which leads to the programmed cell death by different mechanisms. The aim of this study was to evaluate the effects of...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Tehran University of Medical Sciences
2013-09-01
|
| Series: | پیاورد سلامت |
| Subjects: | |
| Online Access: | http://payavard.tums.ac.ir/browse.php?a_code=A-10-1-22&slc_lang=en&sid=1 |